Table 4 Relation between mRECIST and vRECIST methods in assessment of the therapeutic response whether CR, PR, SD or PD
mRECIST | |||||||||
|---|---|---|---|---|---|---|---|---|---|
SD | PR | PD | CR | ||||||
Count | Percentage | Count | Percentage | Count | Percentage | Count | Percentage | ||
vRECIST | SD | 10 | 28.6% | 1 | 9.1% | 0 | .0% | 0 | .0% |
PR | 25 | 71.4% | 10 | 90.9% | 0 | .0% | 0 | .0% | |
PD | 0 | .0% | 0 | .0% | 1 | 100.0% | 0 | .0% | |
CR | 0 | .0% | 0 | .0% | 0 | .0% | 3 | 100.0% | |
Measure of agreement | Kappa | P value | |||||||
.244 | .001 | ||||||||